AIC
GNCA

AWM Investment Company’s Genocea Biosciences, Inc. GNCA Stock Holding History

AWM Investment Company’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-532,516
Closed -$1.22M – 107
2020
Q3 		$1.22M Buy
+532,516
New +$1.4M 0.2% 73
2016
Q3 		– Sell
-97,356
Closed -$3.19M – 108
2016
Q2 		$3.19M Sell
97,356
-10,769
-10% -$395K 0.68% 47
2016
Q1 		$6.7M Buy
108,125
+18,750
+21% +$596K 1.41% 28
2015
Q4 		$3.77M Buy
89,375
+27,862
+45% +$1.33M 0.74% 38
2015
Q3 		$3.37M Buy
+61,513
New +$6.1M 0.65% 42

Other funds holding GNCA

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AWM Investment Company's GNCA Position: Q4 2020 in Review

AWM Investment Company sold out of Genocea Biosciences, Inc. (GNCA) in Q4 2020, closing a stake of 532,516 shares — an estimated $1.22M sold.

AWM Investment Company first reported a position in GNCA in Q3 2015 and held it in 5 quarters. The position peaked at $6.7M in Q1 2016. 39 funds tracked by Wall St. Rank hold GNCA as of Q4 2020.

  • AWM Investment Company reported no remaining Genocea Biosciences, Inc. position as of Q4 2020 after selling out during the quarter.
  • AWM Investment Company sold 532,516 Genocea Biosciences, Inc. shares in Q4 2020, an estimated $1.22M.
  • AWM Investment Company first reported a position in Genocea Biosciences, Inc. in Q3 2015 and held it in 5 quarters.
  • AWM Investment Company's Genocea Biosciences, Inc. position peaked at $6.7M in Q1 2016.
  • 39 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q4 2020.

Based on AWM Investment Company's 13F filing for Q4 2020, filed 12 Feb 2021.